A Protracted Course of COVID19 Infection in a Metastatic Breast Cancer Patient During CDK4/6 Inhibitor Therapy

We describe the first case report of a patient with COVID19 infection and metastatic breast cancer, while on systemic therapy with a CDK4/6 inhibitor. The patient had unique disease course, characterized with delayed symptomatology. The case highlights novel findings and stress careful and extended...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Albert Grinshpun, Irit Merlet, Hila Fruchtman, Dean Nachman
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-06-01
Subjects:	COVID19 metastatic breast cancer CDK4/6 inhibitors pneumonia palbociclib
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2020.01085/full